Close Menu

At the CED Life Sciences Conference this week, Sanofi CEO Chris Viehbacher said that researchers who work for big pharma tend to be the least innovative, reports Pharmalot's Ed Silverman. The best scientists, Viehbacher said, work for small biotechs — that's why Sanofi is reducing its internal research capacity and partnering with outside companies, biotechs, and universities to get R&D done.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.